Retrospective study: China's pediatric hospital infections before and during the COVID-19 pandemic
DOI:
https://doi.org/10.3855/jidc.20672Keywords:
COVID-19, pediatrics, intensive care units, infection controlAbstract
Introduction: The COVID-19 pandemic probably influenced the incidence of healthcare-associated infections (HAIs) in pediatric hospitals. This study aimed to assess HAIs and the impact of multidrug-resistant organisms in pediatric intensive care units (ICUs) before and during the pandemic.
Methodology: This retrospective study was conducted at the Children's Hospital of Soochow University from January 2017 to December 2022, covering various ICU units. Statistical analyses compared HAI rates, including Ventilator-associated pneumonia (VAP), central line-associated bloodstream infections (CLABSI), and catheter-associated urinary tract infections (CAUTI), and the prevalence of multidrug-resistant pathogens.
Results: Child hospital admissions were analyzed, with 185,116 admissions pre-pandemic and 218,681 during the pandemic. The average length of stay (LOS) increased across ICU units. Overall, the HAI rates declined from 2.7 to 1.79 (p < 0.01) with NICU rates decreasing from 2.93 to 2.07 (p < 0.01) and SICU rates from 7.17 to 4.56 (p < 0.01) except for general ICUs. VAP rates declined in the general ICU and NICU, while the rates in the SICU remained statistically unchanged. The CLABSI and CAUTI rates remained stable across all ICUs. The total count of multidrug-resistant bacteria increased by 41 instances with significant increases in gram-negative bacteria, particularly CRPA (13%) and CRAB (3%), while MRSA decreased by 12%. CRE strains decreased by 10 counts in the NICUs, while CRAB increased by 12 in the general ICUs and by 8 in the SICUs.
Conclusions: This study reveals a significant HAI decline in pediatric hospitals during the pandemic, suggesting implications for pediatric ICU infection control.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Min Shi, XUE SHI

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Funding data
-
Suzhou Municipal Health Commission
Grant numbers KJXW2021049

